- Home
- HURA vs LFCR Comparison
HURA vs LFCR Comparison
Compare HURA & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HURA | LFCR |
|---|---|---|
| Founded | 2009 | 1986 |
| Country | United States | United States |
| Employees | 22 | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 160.5M | 190.9M |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | HURA | LFCR |
|---|---|---|
| Price | $2.07 | $4.39 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $9.50 | $6.00 |
| AVG Volume (30 Days) | ★ 327.9K | 149.3K |
| Earning Date | 05-15-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $557,559,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $5.04 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 6.36 |
| 52 Week Low | $0.41 | $3.63 |
| 52 Week High | $3.90 | $8.98 |
Technical Indicators
Market Signals| Indicator | HURA | LFCR |
|---|---|---|
| Relative Strength Index (RSI) | 37.88 | 33.10 |
| Support Level | $1.82 | $4.22 |
| Resistance Level | $2.20 | $5.34 |
| Average True Range (ATR) | 0.14 | 0.26 |
| MACD | -0.03 | -0.04 |
| Stochastic Oscillator | 1.32 | 3.30 |
Price Performance
Historical ComparisonAbout HURA TuHURA Biosciences Inc.
TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.